Get my own profile
Public access
View all27 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Christian ObingerPROFESSOR DER PROTEINBIOCHEMIE, BOKU - Austria, Department of Chemistry, Institute of BiochemistryVerified email at boku.ac.at
- Benjamin SalzerAstraZenecaVerified email at astrazeneca.com
- Charlotte ZajcUniversity of Natural Resources and Life SciencesVerified email at boku.ac.at
- Manfred LehnerSt. Anna Kinderkrebsforschung GmbHVerified email at ccri.at
- Karl Dane WittrupProfessor of Chemical Engineering & Biological Engineering, Massachusetts Institute of TechnologyVerified email at mit.edu
- Kristina Djinovic-CarugoEMBL Grenoble, FR & Dept Struct Compt Biol, Perutz Labs, Univ of Vienna, ATVerified email at univie.ac.at
- Jonathan D KieferETH ZürichVerified email at ethz.ch
- Seymour de PicciottoPh.D. Candidate in Biological Engineering, Massachusetts Institute of TechnologyVerified email at mit.edu
- Chris OostenbrinkUniversity of Natural Resources and Life Sciences, ViennaVerified email at boku.ac.at
- Omer DushekProfessor, University of OxfordVerified email at path.ox.ac.uk
Follow
Michael W. Traxlmayr
Head of the BOKU-module of the CD Lab for Next Generation CAR T Cells, BOKU University
Verified email at boku.ac.at